than 30 million surgical procedures performed annually in the United States (US). Of those, 2-5% will develop a SSI, or one out of every 24 patients who have inpatient surgery. With shortened hospital stays and an increase in ambulatory surgical centers, the incidence of SSis is on the rise . Edmiston et al. (2008) reported that the probability of a patient developing a postoperative SSI is influenced by selected intrinsic, patient-related risk factors and extrinsic, procedure-related risk factors. described the various patient-related risk factors that may contribute to the development of a SSI. Risks factors are separated into patient-related (preoperative), procedure-related (perioperative), and post operative categories (Table 1 ) . These risk factors can either be modifiable or unmodifiable. An example of an unmodifiable risk factor is age; the most common and modifiable risk factor would be poorly controlled diabetes (Anderson et al.) . The timely administration, selection, and dosage of appropriate preoperative prophylactic antibiotics is an important element in the prevention of a SSI. According to Zaidi, Tariq, and Breslin (2009) SSis. Based on SCIP's current evidence based guidelines, antibiotics should be administered within 60 minutes of the surgical incision, and within 120 minutes for the administration of vancomycin and fluoroquinolones (Bratzler & Hunt, 2006) . The appropriate timing of the antibiotic should attain optimal tissue and serum drug levels and then be maintained throughout the surgical procedure (Meeks et al. , 2011) . The selection of the antibiotic should be based on the procedure and the published evidence-based recommendations (Anderson et al., 2008) . To encourage appropropriate antibiotic prophylaxis, the CDC, CMS, and The Joint Commission (TJC) have adopted performance measures that specify the choice, timing, and duration of prophylactic antibiotics. Organizations are expected to adhere to these measures, and facility compliance is now publicly reported on a government website that can be found at http:///www.hospitalcompare.hhs.gov (Steinburg et al., 2009) . Despite the high-quality evidence to support preventative guidelines and improve patient outcomes, compliance with the guidelines is suboptimal in many hospitals, usually due to patient, provider, and system level factors (Meeks et al., 2011) . With the movement toward public reporting of quality performance measures and fmancial incentives such as pay-for perfomance, noncompliance with SCIP guidelines can have significant consequences for healthcare organizations (Bratzler & Hunt, 2006) . 
SSI Definition and Impact
Historically, surgical complications were thought to be inevitable. Development of a SSI was predictable, simply a risk of the surgical business. It is now estimated that as many as 60% of SSis are preventable, mostly related to the use of recommended evidence-based practices such as the timing, selection, and duration of preoperative prophylactic antibiotics (Meeks et al., 2011 ) . According to Fry and Fry (2007) , a SSI is an unexpected event that adversely affects a patient, complicates the postoperative course, and results in a poor outcome. Owens and Stoessel (2008) defined a SSI as an infection that has occurred within 30 days of an operative procedure or within one year if an implant has been left in place. These infections may be superficial, deep incisional or involve an organ or body space. SSis are still a major cause of morbidity and mortality in spite of all the improvements in infection control techniques and in surgical practice
Bucher, Warner, and Dillon (2011) completed a review of the literature that examined SSis and prophylactic antibiotics. The purpose of their review was to highlight the progress that has been occurring with regard to the understanding of SSis and to identifY the current role of antimicrobial prophylaxis in the prevention of a SSI.
The authors discussed some original studies that mainly focused on procedural risk factors for developing a SSI. For example, they refer to the CDC wound classification system that is still widely used today. This classification system is based on predicting the degree of bacterial contamination by identifYing those procedures in which the likelihood of developing a SSI exists. For a SSI to occur, microbial contamination of the surgical wound must occur at the time of surgery. For many patients the comtarnination occurs from endogenous flora either from the skin or exposed hollow viscus. Exogenous floral contamination of a surgical wound can transfer from operating room personnel, equipment, implants, or the medication that is administered during the procedure. There are few organisms to blame for many of the SSis. Grampositive organisms are largely responsible for the majority of SSis in class I wounds.
In class II and III wounds, endogenous Gram-negative organisms contributed to SSis when a hollow visus is entered. The emergence of resistant organisms that are isolated from the surgical wound is becoming a major concern with regards to the development of a SSI. In particular methicillin-resistant staph aureus (MRSA) and the percentage of infections attributed to MRSA has dramatically increased. It has been found that MRSA accounts for 23% of all Gram-positive isolates and 20% of all SSI isolates.
Also patients with MRSA attributed SSis had longer hospital stays, increased cost of care, and higher mortality rates. The authors go on to say that currently the CDC does not recommend routine antibiotic prophylaxis to cover MRSA except in certain clinical circumstances. It depends on the type and location of the MRS A.
Antimicrobial prophylaxis is an attempt to reduce the risk of a SSI by timing the administration of an antibiotic to match the potential intra-operative wound There is considerable cost associated with the development of a SSI. The expense varies widely depending on the severity of the infection and treatment course. Barnett (2007) reported that each SSI causes an additional 7-10 postoperative hospital days.
Depending on the type of infection and infecting pathogen, the cost of treating a SSI ranges from $3 ,000-$29,000 and adds up to $10 billion annually (Barnett) ; the cost when due to a resistant organism is likely even higher . Most estimates are based on inpatient costs and do not account for the additional costs of rehospitalization, post-discharge outpatient expenses, and any long term disabilities (Barnett, 2007) . SSis pose a substantial clinical burden (Owens & Stoessel, 2008 The mean extra hospital duration was 6.5 days, and in a SSI involving organs or body space, there was even a longer hospital duration and increased costs compared with a SSI that only involved the incision or was superficial in nature.
Morbidity and mortality is associated with SSis. Patients that develop a SSI are up to 60% more likely to spend time in the Intensive Care Unit (ICU), where care is costly for both the patient and hospital (Barnett, 2007) . The patient with a SSI is five times more likely to be readmitted to the hospital (Fry & Fry, 2007) , and 77% of deaths among patients with a SSI are directly attributable to the SSI. Potentially preventable complications are estimated to add 9.4%-9.7% to hospital inpatient costs (Fuller, McCullough, Bao, & Averill, 2009 ).
Evidence Based Guidelines and Initiatives for Prevention of SSis
CMS created the Surgical Infection Prevention Collaborative (SIP) (Anderson et al., 2008) . This project has led to a reduction in surgical complications as a result of healthcare professionals' attitudes toward surgery (Clancy, 2008) . CMS estimates that compliance with the SCIP measures will help prevent up to 13,027 perioperative deaths and 271 ,055 surgical complications annually for Medicare patients alone (Bratzler & Hunt, 2006 ).
On the federal government level, healthcare organizations must meet SCIP requirements in order to be reimbursed for services rendered. Anderson et al. (2008) described the creation of the Deficit Reduction Act in 2005 that requires acute care hospitals that are paid by Medicare to submit quality measure information to CMS as a requirement for reimbursement. This requirement allows CMS to adjust payments downward for those patients that develop a HAL CMS now requires inclusion of prophylactic antibiotics within one hour of surgery and antibiotics to be discontinued within 24 hours after surgery as a quality measure for payment.
Research Regarding Evidence Based Strategies
In 1999, the Infection Control Advisory Committee that is part of the CDC published guidelines that outlined the principles of prophylactic antibiotic administration for surgical practice. The guidelines include: identification of procedures that would benefit from prophylactic antibiotics; drug of choice for selected procedures; recommended timing of the antibiotics; duration of use; and discontinuing antibiotics. Another tool that perioperative practitioners can use that addresses data collection and analysis related to
SSI prevention is the Specifications Manual for National Hospital Inpatient Quality
Measures (Appendix B). These guidelines represents a collaborative effort between CMS and TJC, and provide algorithms that outline prophylactic antibiotic administration as well as the correct antibiotic for particular procedures (Wanzer, Goeckner, and Hicks , 2011) .
Accurate and timely administration of antibiotics is a critical element in perioperative care (Wanzer et al., 2011) , and the most important factors in the prevention ofSSis are meticulous aseptic technique and the timely administration of selected preoperative antibiotics . The goal of antibiotic prophylaxis is to prevent a SSI by reducing the microorganisms at the surgical site during the operative procedure. The efficacy of antibiotic prophylaxis for reducing a SSI has been clearly established (Anderson et al.) . Patients who receive prophylactic antibiotics within one hour to two hours before surgical incision have lower rates of SSI than those patients who receive antibiotics closer to the time of incision. However, errors in selection or dose of prophylactic antibiotics are common. Among 34,133 patients undergoing surgery in centers around the US, an antibiotic administered within one hour of the incision occurred in only 56% of patients (Anderson et al.) Timing, Selection and Dosage Classen et al. (1992) conducted a prospective observational study of2,847 patients that underwent elective clean or clean contaminated procedures at a large community hospital. Of the 1708 patients who received the prophylactic antibiotic preoperatively, or two hours before surgical incision, only 10 developed a SSI. In 282 patients that received the antibiotic perioperatively, or three hours after surgical incision, only four developed a SSI (p = .12) compared with the perioperatively treated group. Of 488 patients who received an antibiotic postoperatively, more than three hours but less than 24 hours after surgical incision, 16 patients developed a wound infection (p < .0001).
Lastly, patients that had the antibiotic administered early, 2-24 hours before surgery, 14
developed an infection (p < .0001). The investigators noted that this analysis confirmed their suspicions that the administration of an antibiotic in the perioperative period was associated with a lower risk of the patient developing a SSI. They concluded that the administration of prophylactic antibiotics is significantly varied in institutions, but administration of antibiotics two hours prior to surgical incison will reduce the probability of developing a SSI. prophylactically with a 2 gm dose of cefazolin preoperatively. They were then followed by a second dose of antibiotics at three hours. There were 38 patients and each was assigned to one of three body mass index (BMI) groups: A group (n = 17) with a BMI 40-49; B group (n = 11) with a BMI 50-59; and group C (n = 10) with a BMI greater than 60. There were multiple, timed serum levels obtained at baseline, during surgical incision, and at 15, 30, and 60 minutes prior to the administration of the second dose of prophylactic antibiotic. Tissue that included skin, subcutaneous fat, and omentum was also collected and analyzed by microbiological assay to determine the cefazolin concentrations. The analysis revealed that over 90% of the serum samples had therapeutic levels that covered 53.8% of gram positive and 76.6% of gram negative surgical pathogens. Therapeutic tissue levels were achieved in only 48.1 %, 28.6%, and These trials demonstrated a considerable benefit for the combination of oral and IV dosed antibiotics compared to only oral doses of prophylactic antibiotics (p = .02).
Twenty-eight trials (N = 3077) studied administration of various types of prophylactic antibiotic. The analysis compared any type of antibiotic with those antibiotics regarded as the "gold standard" in antimicrobial treatment: oral neomycin, erythromycin, IV cefoxitin or cefotetan, and IV doxycycline. The purpose of this analysis was to detect statistical significance from the existing data with regard to those antibiotics deemed as gold standard antibiotics. One trial compared IV ceftriaxone and metronidazole to oral neomycin and erthromycin with substantial benefit however, other ceftriaxone studies did not show a benefit in the prevention of a SWI when this antibiotic was compared to other IV choices. There was an additional trial that resulted in considerable benefit with both oral and IV doses of two gold standard drugs, IV cefoxitin and oral neomycin/erythromycin. These drugs were found to be more effective in combination versus using each alone however, the results of this trial were inconclusive.
From this meta-analysis, Nelson et al. concluded that antibiotic prophylaxis is essential for patients having colorectal surgery. The potential exposure of the operative field to comtarninated colonic contents is enough to warrant the use of prophylactic
antibiotics. An IV antibiotic must be administered before surgery with the best time being one hour before surgical incision however, the investigators acknowledge that determination of the optimal timing of prophylactic antibiotics is currently lacking evidence. The analysis found no need for re-dosing postoperatively, and the antibiotics selected for prophylaxis must cover both aerobic and anaerobic bacteria.
In what was probably the largest multicentered prospective study related to this topic, to report improvement in compliance with SCIP, they stated that there is room for improvement. They reported that the study provided information that can be used to develop intervention to help improve compliance (Meeks et al. ) .
In summary, the research supports the appropriate timing and selection of preoperative prophylactic antibiotics in preventable surgical site infections. However, the evidence is lacking in regard to repeat dosing during surgical procedures lasting greater than four hours. In light ofCMS and TJC ' s "pay for perfomance" initiatives and public reporting, healthcare organizations need to explore the relationship between redosing and the risk of developing a SSI. Research is key to prevention.
Next, the theoretical framework that guided this study will be presented.
Theoretical Framework
The formulate a nursing diagnosis, and select those interventions that will aid in prevention of an SSI ("Standards ofPerioperative Nursing," 2011).
In the next section, the method used in this study will be presented.
Methodology Purpose/Specific Aims
The purpose of this study was to evaluate the timely administration, appropriate selection, and dosage of preoperative prophylactic antibiotics, and the impact in the prevention of surgical site infections.
Research Question
The research question was: What impact did the timing and selection of prophylactic antibiotics have on preventable surgical site infections.
Design
This research study utilized a retrospective design with chart audits (Po lit & Beck,
2008).

Site and Sample
This study was conducted at a community hospital in Rhode Island. The sample included patients who underwent surgery at the study site who met the inclusion criteria:
adults undergoing elective and emergent colon, hysterectomy, hip, and knee arthroplasty.
This subset was selected because these procedures have specific recommendations from SCIP regarding preoperative antibiotic prophylaxis. Exclusion criteria included: less than 18 years of age; a hospital length of stay greater than 120 days; underwent any procedure performed entirely by a laparoscope; a documented infection prior to the surgical procedure; any diagnosis suggestive of a preoperative infectious disease; receiving antibiotics more than 24 hours prior to surgery (except colon surgery). A target sample of 100 was desired. Based on the surgical volume, this researcher collected data on every 3rd surgical procedure that met the inclusion criteria. All records were first reviewed for inclusion criteria and if not met, were excluded. Data collected were de-identified and stored in a locked file accessible only to the researcher. If any data was missing, the patient record was excluded from the study and the data collection tool was destroyed.
Measurement
After determining eligibility, a data collection tool developed by this researcher was used to collect relevant data (Appendix D). Using the subjects' medical record number as the identifier, demographic information was obtained that included sex, age, weight, BMI (body mass index), male or female gender, and any co-morbidities. This researcher then utilized SCIP data obtained from QI to collect information from the subjects' medical record that included the type of surgery/procedure, including surgical start and stop times. Risk factors for infection were evaluated including: diabetes/type; smoking history; previous infections; infectious disease present ( e.g. MRSA); recent hospitalizations; antibiotics administered in the past 24 hours; and oral prophylaxis for colon surgery (if applicable). Data related to the timing of prophylactic antibiotics, the name/type of antibiotic administered, repeat dosing for surgical procedures greater than four hours, and if the patient received preoperative antibiotic prophylaxis were collected.
Any re-dosing of antibiotic during the surgical procedure was included in the data collection only if the patient had received a preoperative prophylactic antibiotic.
To identify SSI infections from the sample, the IPC provided a list of reported SSis during the timeframe of this study. Any data relevant to the infection was also documented in this researcher's data collection tool. The data collected from both the QI and IPC departments were entered into a Microsoft Excel® database that was created and maintained by the researcher. There is no computer software in the hospital that enables the QI and IPC departments to correlate their data with respect to SSis and antibiotic administration or timing.
Timeframe
Data collection for this study was completed over an 6 month time period.
Human Subjects Considerations
This was a retrospective design and thus patient consent was not needed. Data collected included the medical record number but only for selection of the correct medical record. Once the data collection record was completed for a subject, the medical record number was removed. Anonymity and confidentiality was maintained throughout the study. Data was collected by the researcher and stored in a locked file that only the researcher and faculty advisor had access to. All data collected was destroyed immediately upon completion of the study.
Data Analysis
Data gathered were entered into an Microsoft Excel® spreadsheet for the purposes of organizing patient data. The exact timing of prophylactic antibiotic administration before incision and the start of the surgical procedure was calculated in minutes and entered into a frequency distribution table. The mean, median, and mode of all the selected surgical procedures were determined along with IPC data to correlate the incidence of a documented SSI within the tirneframe of this study.
Results
Overall, I 00 medical records were reviewed, with 82 (82%) comprising the sample, and 18(18%) records excluded due to incomplete records. The sample included 54 (54%) females and 28 (28%) males, and the mean age was 65.42 years with a range of 40-91 years.
The sample identified by procedure included: 15 colorectal cases (23.07%); 12 hysterectomy cases (18.46%), 25 total knee arthroplasty cases (38.46%); and 30 total hip arthroplasty cases ( 46.15% ).
Body mass index (BMI) was calculated to determine the need for weight-adjusted dosing in a subset of subjects , those with a BMI greater than 30. The mean BMI for all subjects was 25.8. Twenty-two subjects had a BMI of greater than 30, indicating obesity, with a mean BMI of36.51. No weight adjusted dosing was detected for any of those subjects with a BMI greater than 30. Prophylactic antibiotic dose was administered 0-29 minutes before surgical incision in 27 cases (32.9%). In another 54 cases (65%), the prophylactic antibiotic was given 30-60 minutes before surgical incision. The mean time of antibiotic administration was 31.23 minutes. There were two cases in which the procedure lasted greater than four hours, with no re-dosing in either case. In more than half of the colon (53%) and hysterectomy (58%) procedures, the prophylactic antibiotic was administered in a 0-29 minute timeframe, whereas in the total hip (72%) and total knee (60%) arthroplasty cases, the antibiotic was given within a 30-60 minute timeframe.
Compliance with the choice of antibiotic did meet SCIP recommendations in all procedures (100%). There was no re-dosing (0%) for colon and hysterectomy procedures that lasted greater than 4 hours, and no (0%) procedure adjusted the dose of antibiotic based on weight or BMI. Compliance with SCIP selection of antibiotics by type of procedure as well as the timing, and administration of antibiotics are illustrated in Table 3 . Table 5 illustrates the sample participants who were identified as having a SSI.
Overall, this table demonstrates that the selection of antibiotic for those procedures resulting in a SSI did meet the SCIP recommendations. The timing of the antibiotic in those cases where the administration of the antibiotic is less than 30 minutes prior to incision does meet SCIP recommendations, however this is not considered optimal timing for adequate tissue perfusion. During this time period, there were eight documented SSis, three involving an organ space and five that were superficial. 
Summary and Conclusions
In summary, this study evaluated the timely administration, appropriate selection, and dosage of preoperative prophylactic antibiotic in surgical patients. A retrospective research design was used to obtain data from 100 randomly selected colon, hysterectomy, total hip and total knee arthroplasty cases. These cases were then evaluated for the presence of a SSI. In more than half of the colon and hysterectomy cases, it was found that the prophylactic antibiotic was administered less than 30 minutes before surgical incision, and in more than half of the total hip and total knee arthroplasty cases, the antibiotic was administered in the 30-60 minute timeframe. The timeframe allows for adequate tissue perfusion as recommended in much of the literature. All the procedures met the SCIP recommendations for timing and selection of prophylactic antibiotic;
however the evidence does support that adherence to the SCIP guidelines is necessary to reduce the risk of a SSI. The incidence of infection while relatively small does support the need for further investigation with regard to the timing of the prophylactic antibiotic and the need for prevention of further SSis.
There were some limitations encountered while conducting this study. This researcher experienced difficulty locating specific subject data due to a hybrid charting system within the community hospital. The anesthesia record is completely on paper while the nursing documentation is all electronic. There was a portion of study data that had to be excluded due to incomplete documentation of the timing, selection, and dosage of prophylactic antibiotic. Secondly, the QI and IPC departments do not have software programs that communicate relevant data with regards to SCIP measures and patient infections. Both operating systems function independently, making correlation of data very time consuming. Lastly, the IPC department tracks those surgical infections reported by the surgeons or when a surgical patient is readmitted to the hospital. The accuracy with which a SSI is reported cannot always be determined and in most situations is based solely on notification from the surgeon.
Based on the fmdings of this study, it can be concluded that these practices were consistent with the guidelines. The timing of the preoperative prophylactic antibiotic did meet the SCIP guidelines of administration within one hour before surgical incision.
However, the evidence clearly supports administration of the antibiotic within the optimal timeframe of between 30-60 minutes for adequate tissue perfusion and for prevention of a SSI. In all cases of a SSI, the selection of antibiotic were ones identified from the SCIP recommended list of antibiotics. There-dosing of the antibiotic for procedures lasting greater than four hours did not occur in all the surgical cases, and weight adjusted dosing did not occur despite the significant number of patients identified as obese.
Improvements can be made with regards to the timing and administration of preoperative prophylactic antibiotic. A recommendation will be made to the community hospital's Anesthesia and Surgical Department proposing that the prophylactic antibiotic be hung via IV in the preoperative holding unit and immediately prior to transfer to the operating room the antibiotic would be started. This would ensure that the preoperative prophylactic antibiotic is given within the 30-60 minute timeframe, thus reducing the potential for the development of a SSI and improving patient outcomes.
Recommendations and Implications
One of the primary roles of the Advanced Practice Registered Nurse (APRN) is to improve the quality of patient care. This researcher identified a quality improvement opportunity that had the potential to improve patient safety and outcomes and enhance Department is needed to develop a protocol for initiating the prophylactic antibiotic in the pre-operative unit. This protocol would ensure that the timing of the antibiotic is within an optimal timeframe and that adequate tissue perfusion would occur.
In the study facility, it was primarily the Department of Anesthesia that administered the preoperative prophylactic antibiotics. The evidence supporting the administration of the prophylactic antibiotic within a 30-60 minute timeframe, as well as the results of this study, will be shared with the Anesthesia Department, Surgical Services Department, IPC and QI Departments. Recommendations for change will be discussed and extensive education and training must be provided to staff in all departments of Surgical Services to make this initiative successful. This quality practice change has the potential to improve patient outcomes by reducing the risk of developing a SSI and thus reduce any costs incurred to the hospital for the treatment of a SSI. Any improvement process related to the prevention of SSis must be driven by the leadership within the healthcare organization. Involvement of a multidisciplinary team is essential in a SSI improvement project. This team should meet regularly to examine performance on antibiotic administration as well as the other SCIP measures, review pertinent hospital data, implement changes for improvement, and review the results.
Process and system changes need to occur within the healthcare organization to improve and paper standing orders that include the specifics related to the antibiotic timing, dose, and discontinuance is necessary for compliance The possible development of a pharmacist and/or nurse driven protocol that would include the type of antibiotic selection and dose and all based on SCIP guidelines should be considered. The responsibility for the dosing of the antibiotic should be assigned to either anesthesia or a designated nurse to improve the timeliness. A visible reminder or checklist to remind staff to give an antibiotic could be developed and implemented in the preoperative areas.
The involvement of pharmacy, infection control and nursing should occur to ensure that the prophylactic antibiotics are selected and given in a timely manner. The CNS is trained and well prepared to assume a leadership role within the inter-disciplinary team to assure that high quality care remains an institutional priority.
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